Literature DB >> 21917083

Patient-reported outcomes and gut dysmotility in functional gastrointestinal disorders.

R F Cogliandro1, A Antonucci, R De Giorgio, G Barbara, C Cremon, L Cogliandro, C Frisoni, R Pezzilli, A M Morselli-Labate, R Corinaldesi, V Stanghellini.   

Abstract

BACKGROUND: Unlike chronic idiopathic intestinal pseudo-obstruction (CIIP), severe digestive syndromes that are not characterized by episodes resembling mechanical obstruction remain poorly characterized. The present study compared clinical features, small bowel motility, and quality of life (QoL) in patients with CIIP or severe functional gastrointestinal disorders (SFGID), compared to irritable bowel syndrome (IBS).
METHODS: We enrolled 215 consecutive patients: 70 CIIP, 110 malnourished SFGID [body mass index (BMI) 17.8±1.8kg m(-2) ] and 35 non-malnourished SFGID (BMI 22.8±3.6kgm(-2) ). KEY
RESULTS: Abnormal motor patterns that fulfilled diagnostic criteria for small bowel dysmotility were virtually absent in IBS patients, but were recorded in69 CIIP patients (98.6%), 82 malnourished SFGID patients (74.5%;), and 23 SFGID patients without malnutrition (65.7%) (P<0.0001). CIIP patients presented more frequently abnormal activity fronts, lack of response to feeding, and hypomotility than malnourished and non-malnourished SFGID patients (61.4%vs 42.7% and 31.4%, P<0.05 only vs non-malnourished SFGID; 8.6%vs 0.9% and 2.9%; 21.4%vs 0.9% and 0%, P<0.05). Quality of life mean scores were all significantly lower in CIIP patients and malnourished SFGID patients than in IBS. Bodily pain, general health, and vitality scores were lower in CIIP also compared to non-malnourished SFGID. CONCLUSIONS & INFERENCES: Chronic idiopathic intestinal pseudo-obstruction and SFGIDs are frequently associated with small bowel dysmotility and marked derangements of QoL which are significantly more severe than in IBS and result particularly in being severe in patients with recurrent sub occlusive episodes or inability to maintain a normal body weight.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21917083     DOI: 10.1111/j.1365-2982.2011.01783.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  16 in total

Review 1.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 2.  Small Bowel Motility.

Authors:  Carolina Malagelada; Juan R Malagelada
Journal:  Curr Gastroenterol Rep       Date:  2017-06

Review 3.  Small Bowel Dysmotility, Pseudoobstruction, and Functional Correlation with Histopathology: Lessons Learned.

Authors:  Zorisadday Gonzalez; Richard McCallum
Journal:  Curr Gastroenterol Rep       Date:  2020-02-20

4.  Gut epithelial and vascular barrier abnormalities in patients with chronic intestinal pseudo-obstruction.

Authors:  Elisa Boschetti; Anna Accarino; Carolina Malagelada; Juan R Malagelada; Rosanna F Cogliandro; Alessandra Gori; Vitaliano Tugnoli; Fiorella Giancola; Francesca Bianco; Elena Bonora; Paolo Clavenzani; Umberto Volta; Giacomo Caio; Catia Sternini; Vincenzo Stanghellini; Fernando Azpiroz; Roberto De Giorgio
Journal:  Neurogastroenterol Motil       Date:  2019-05-29       Impact factor: 3.598

5.  Enteric neuron density correlates with clinical features of severe gut dysmotility.

Authors:  Elisa Boschetti; Carolina Malagelada; Anna Accarino; Juan R Malagelada; Rosanna F Cogliandro; Alessandra Gori; Elena Bonora; Fiorella Giancola; Francesca Bianco; Vitaliano Tugnoli; Paolo Clavenzani; Fernando Azpiroz; Vincenzo Stanghellini; Catia Sternini; Roberto De Giorgio
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

Review 6.  New perspectives in the diagnosis and management of enteric neuropathies.

Authors:  Charles H Knowles; Greger Lindberg; Emanuele Panza; Roberto De Giorgio
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-12       Impact factor: 46.802

7.  Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS).

Authors:  Mariette Bengtsson; Oskar Hammar; Thomas Mandl; Bodil Ohlsson
Journal:  BMC Gastroenterol       Date:  2011-11-10       Impact factor: 3.067

8.  Pimpinella anisum in the treatment of functional dyspepsia: A double-blind, randomized clinical trial.

Authors:  S Ashraffodin Ghoshegir; Mohammad Mazaheri; Alireza Ghannadi; Awat Feizi; Mahmoud Babaeian; Maryam Tanhaee; Mehrdad Karimi; Peyman Adibi
Journal:  J Res Med Sci       Date:  2015-01       Impact factor: 1.852

9.  A randomised, controlled study of small intestinal motility in patients treated with sacral nerve stimulation for irritable bowel syndrome.

Authors:  Janne Fassov; Lilli Lundby; Jonas Worsøe; Steen Buntzen; Søren Laurberg; Klaus Krogh
Journal:  BMC Gastroenterol       Date:  2014-06-25       Impact factor: 3.067

10.  Is this the era of interstitial cells of cajal transplantation?

Authors:  Kyung Sik Park
Journal:  J Neurogastroenterol Motil       Date:  2014-07-31       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.